{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "OPHT",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 166972000
            },
            {
                "label": "Available for sale securities",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Due from Novartis Pharma AG",
                "concept": "ReceivablesLongTermContractsOrPrograms",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 3146000
            },
            {
                "label": "Income tax receivable",
                "concept": "IncomeTaxesReceivable",
                "unit": "usd",
                "value": 1387000
            },
            {
                "label": "Current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 171505000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 518000
            },
            {
                "label": "Deferred tax assets",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 3529000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 24000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 175576000
            },
            {
                "label": "Accrued research and development expenses",
                "concept": "opht:AccruedResearchAndDevelopment",
                "unit": "usd",
                "value": 4984000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 7551000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 12535000
            },
            {
                "label": "Deferred revenue, long-term",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Royalty purchase liability",
                "concept": "RoyaltyGuaranteesCommitmentsAmount",
                "unit": "usd",
                "value": 125000000
            },
            {
                "label": "Liabilities and Stockholders' Equity (Deficit)",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 137535000
            },
            {
                "label": "Preferred stock\u2014$0.001 par value, 5,000,000 shares authorized, no shares issued or outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock\u2014$0.001 par value, 200,000,000 shares authorized, 36,110,298 and 35,733,276 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 36000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 522759000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -484754000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Balance at beginning of period",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 38041000
            },
            {
                "label": "Liabilities and Stockholders' Equity (Deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 175576000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 114205000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2763000
            },
            {
                "label": "Amortization of premium and discounts on investment securities",
                "concept": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
                "unit": "usd",
                "value": -140000
            },
            {
                "label": "Gain on sale of marketable securities",
                "concept": "AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": -3366000
            },
            {
                "label": "Share-Based Compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 18171000
            },
            {
                "label": "Excess tax benefits from share-based compensation",
                "concept": "ExcessTaxBenefitFromShareBasedCompensationOperatingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Income tax receivable",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": 1387000
            },
            {
                "label": "Due from Novartis Pharma AG",
                "concept": "IncreaseDecreaseInContractReceivablesNet",
                "unit": "usd",
                "value": -3531000
            },
            {
                "label": "Prepaid expense and other current assets",
                "concept": "opht:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets",
                "unit": "usd",
                "value": 68000
            },
            {
                "label": "Accrued interest receivable",
                "concept": "IncreaseDecreaseInAccruedInterestReceivableNet",
                "unit": "usd",
                "value": -466000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -438000
            },
            {
                "label": "Accrued research and development expenses",
                "concept": "opht:IncreaseDecreaseInAccruedResearchAndDevelopment",
                "unit": "usd",
                "value": -42256000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -4481000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -209977000
            },
            {
                "label": "Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -121821000
            },
            {
                "label": "Purchase of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 12014000
            },
            {
                "label": "Sale of marketable securities",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Maturities of marketable securities",
                "concept": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 166806000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from sale of assets",
                "concept": "ProceedsFromSaleOfProductiveAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 154792000
            },
            {
                "label": "Proceeds from stock option/warrant exercises",
                "concept": "opht:ProceedsFromStockOptionsAndWarrantsExercised",
                "unit": "usd",
                "value": 71000
            },
            {
                "label": "Excess tax benefits from share-based compensation",
                "concept": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 71000
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 33042000
            },
            {
                "label": "Income taxes paid (received), net",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": -245000
            },
            {
                "label": "Change in unrealized gain (loss) on available for sale securities, net of tax",
                "concept": "AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax",
                "unit": "usd",
                "value": 212000
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 114205000
            },
            {
                "label": "Unrealized gain (loss) on available for sale securities, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 212000
            },
            {
                "label": "Other comprehensive income (loss)",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 212000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 114417000
            },
            {
                "label": "Collaboration revenue",
                "concept": "SalesRevenueServicesNet",
                "unit": "usd",
                "value": 209977000
            },
            {
                "label": "Research and Development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 66289000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 35683000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 101972000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 108005000
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": 1522000
            },
            {
                "label": "Other income (expense)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -34000
            },
            {
                "label": "Income (loss) before income tax benefit",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": 109493000
            },
            {
                "label": "Income tax benefit",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -4712000
            },
            {
                "label": "Net income (loss) per common share:",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 3.18
            },
            {
                "label": "Dilutive (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 3.17
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 35919000
            },
            {
                "label": "Dilutive (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 36007000
            }
        ]
    }
}